Description
GLP3-RT an investigational triple-agonist studied for its activity at three hormone receptors: GLP-1, GIP, and Glucagon (GCGR). In clinical and preclinical research, GLP-1 and GIP agonism have been associated with appetite suppression, slowed gastric emptying and improved glycemic control. Glucagon receptor activity studied for its role in increasing energy expenditure and promoting breakdown of stored fat and hepatic fat clearance. GLP3-RT remains under clinical investigation and is not an approved pharmaceutical Rx product.
GLP3-RT is supplied as 10mg lyophilized powder, ≥99% purity. For laboratory research use only. Not for human consumption or therapeutic use. Certificate of Analysis available on request. Store at -20°C.
CAS Number: 2381089-83-2
SEQUENCE: GIP/GLP-1/glucagon triple agonist with Aib residues, α-Me-Leu, and a Lys-conjugated (AEEA)-γGlu-C20 diacid; C-terminal serinamide
Amino Acid Chain Length: 39
Molecular Formula: C256H392N64O79
• For Research use only
• Not for human use
• 99% Pure
• Independent Lab Tested

Reviews
There are no reviews yet.